These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33506742)

  • 1. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
    Du W; Lei C; Wang Y; Ding Y; Tian P
    Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2.
    Li Q; Lei C; Lu C; Wang J; Gao M; Gao W
    Cell Death Dis; 2019 Sep; 10(10):698. PubMed ID: 31541081
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Liu Q; Lei C
    Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    Li T; Zhao H; Zhou H; Geng T
    PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
    Tian C; Li X; Ge C
    Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
    Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
    Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling.
    Ying L; Wang J; Feng J; Wu Z
    Mol Biol Rep; 2023 Jul; 50(7):5941-5947. PubMed ID: 37253918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro.
    Guo L; Gao S; Sun W; Wang Y; Zhao J
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101813. PubMed ID: 34583064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
    Wang ZX; Deng TX; Ma Z
    J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2.
    Fang L; Wang SH; Cui YG; Huang L
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1861-1868. PubMed ID: 33660796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
    Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
    Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
    Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F
    Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
    Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses.
    Zhang Y; Yang J; Wang X; Li X
    Sci Rep; 2021 Oct; 11(1):20441. PubMed ID: 34650124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.